Search clinical trials for: Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine

Total 4 results

SENAI CIMATEC

Recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

SARS-CoV-2

Brazil
Azidus Brasil
SENAI CIMATEC

Not yet recruiting

Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine

COVID-19 | COVID-19 Vaccine
Centre Hospitalier Universitaire Vaudois
Immutep S.A.S.

Terminated

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

Melanoma

Switzerland
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany

3

Subscribe